Extended pause for AstraZeneca vaccine
The Norwegian Institute of Public Health has decided to extend the pause in the use of the AstraZeneca vaccine because further investigations are necessary.
Published
Historical Archives: This content is archived and will not be updated.
March
Showing 11 hits
-
-
See signs of protection against COVID-19 among those vaccinated
During the last five weeks, a sharp increase in transmission has been seen among most age groups in Norway, but not among the oldest who have the highest vaccination coverage.
Published
-
UK virus variant associated with higher risk of hospital admission
The UK variant of the coronavirus is associated with a higher risk of being admitted to hospital, even among young adults, according to a new study from the Norwegian Institute of Public Health.
Published
-
AstraZeneca vaccine still on hold in Norway
The Norwegian Institute of Public Health (NIPH) will keep use of the AstraZeneca vaccine on hold in Norway and will continue a thorough review of the situation. An update will be provided at the end of week 12.
Published
-
Norwegian Medicines Agency investigating notification about death
The Norwegian Medicines Agency and the Norwegian Institute of Public Health (NIPH) have received a report of a death following vaccination with the AstraZeneca vaccine.
Published Updated
-
AstraZeneca vaccine: When to consult a doctor
An overview of common side effects after AstraZeneca vaccination, and what people should be alert for, is released by the Norwegian Medicines Agency and the Norwegian Institute of Public Health.
Published
-
Norwegian Medicines Agency notified of blood clots and bleeding in younger people after vaccination with AstraZeneca vaccine
The Norwegian Medicine Agency is asking people who had the AstraZeneca vaccine in the last 14 days and who feel increasingly unwell to be alert.
Published
-
Norwegian Medicines Agency investigating notification about death
The Norwegian Medicines Agency and the Norwegian Institute of Public Health (NIPH) have received a report of a death following vaccination with the AstraZeneca vaccine.
Published
-
Vaccination with AstraZeneca vaccine against COVID-19 put on hold
Following a report in Denmark of a death from a blood clot after receiving the AstraZeneca vaccine, Norway has chosen to suspend vaccination with the AstraZeneca vaccine.
Published
-
Changes in the vaccine strategy
The Norwegian Institute of Public Health will allocate more vaccine doses to areas at particular risk for infection and introduce a new distribution key for vaccines.
Published
-
AstraZeneca vaccine recommended for all over 18 years of age
The Norwegian Institute of Public Health (NIPH) now recommends giving the coronavirus vaccine from AstraZeneca to people over the age of 18.
Published